Therapy for erectile dysfunction (ED) may be speci®c to the cause of ED or it may be nonspeci®c. There are only three causes of ED which have speci®c therapy: psychogenic, endocrine and certain types of reversible vasculogenic ED. In the era of oral therapy for ED, treatment is not causespeci®c in the great majority of patients. For this great majority, only the basic evaluation of ED is needed. Only when there is a strong suspicion that the cause of a patient's ED is endocrine, psychogenic or reversible vascular disease are additional diagnostic tests indicated. In these three categories of patients, speci®c treatment of the cause of ED can produce a permanent and dramatic improvement in sexual function and satisfaction.
Introduction
Most of the current therapies for erectile dysfunction (ED) are nonspeci®c and may be applied to almost any case of ED regardless of the pathogenesis. Examples of nonspeci®c therapy are sildena®l, intracavernous injection therapy, intraurethral therapy, vacuum therapy and penile prosthesis implantation. There are only three causes of ED for which there is speci®c therapy: psychogenic ED, ED due to hypogonadism and some unusual forms of vasculogenic ED. The latter category is limited to young men with primary ED due to congenital arterial or corporovenous occlusive insuf®ciency and young men with arterial insuf®ciency due to pelvic andaor perineal trauma. These forms of vasculogenic ED occur in only a very small percentage of men with ED. An advanced diagnostic evaluation, which may include complete endocrine evaluation, nocturnal penile tumescence rigidity (NPTR) monitoring anda or intracavernous injection (ICI) and other vascular tests, is indicated only when searching for one of the categories of ED which has speci®c therapy. 1 
The standard patient
Well over half of men with ED have a set of similar characteristics. This`standard' patient is over 50 y of age and is in good general medical and psychological health. He has been in a satisfying monogamous relationship for many years. He has experienced gradually progressive ED for at least a year and often for much longer than that.
The pathogenesis of ED in the standard patient has been thought to be arterial andaor corporovenous occlusive insuf®ciency. Recent experience with sildena®l suggests that the pathogenesis may be myogenic, ie dysfunction of the smooth muscle cells of the corpora cavernosa. With regard to the diagnostic evaluation, it is important to realize that the pathogenesis of ED in the standard patient is not one of the three which has speci®c therapy. Therefore, an advanced diagnostic evaluation is not needed. For the standard patient, only the basic evaluation is necessary before initiation of oral therapy.
The basic evaluation of ED for the standard patient should consist of a very careful sexual history, a general medical history, a physical examination, a serum testosterone and blood tests to rule out dyslipidemia, renal failure, hepatic disease and diabetes. Advanced diagnostic tests should be used only when there is strong suspicion that a non-standard patient has endocrine, psychogenic or correctible vascular disease.
Tests for hypogonadism
The proper screening test for ED of endocrine origin has been a matter of debate for years. Serum total testosterone, serum free testosterone and a complete history and physical examination have all been recommended as the most appropriate screening for hypogonadism. This controversy has not been resolved.
Most practitioners screen for hypogonadism with a serum total testosterone. If the initial testosterone is abnormal or if there are clinical signs and symptoms of hypogonadism, a complete endocrine evaluation should be done. The complete evaluation consists of serum total testosterone, serum free testosterone, serum LH and serum prolactin. Some ED experts also test thyroid function at the same time.
Tests for psychogenic causes of ED
There is a psychogenic component in almost every case of ED, whether the psychogenic problem is the primary problem or secondary to an organic abnormality. Often it is dif®cult or impossible to identify whether the psychogenic component is primary or secondary.
Nocturnal penile tumescence and rigidity (NPTR) monitoring may be used to identify whether nocturnal erections are normal or abnormal. NPTR can be monitored by one of two methods. The more accurate and expensive method is a polysomnographic (PSG) study performed in a sleep center for two or three nights. The advantage of PSG studies is that REM sleep is shown to be present or absent during the study. The absence of REM sleep is one reason for a falsely negative NPTR study. The more common method of testing NPTR is to use a monitor in the patient's home for two or three nights. By far the most commonly used home sleep study device is the Rigiscan monitor. Home monitoring has greater convenience and lower cost but less accuracy and reliability because it does not record electroencephalography or electrooculography.
NPTR testing is most useful when a patient reports complete absence of erections during sexual activity but has completely normal erections on the NPTR study. This combination strongly suggests that the patient's erectile dysfunction is psychogenic or ®ctitious. NPTR studies therefore can be used to help differentiate psychogenic from organic problems and resolve medicolegal controversies involving ED.
Visual sexual stimulation (VSS) using erotic audiovisual tapes is preferred over NPTR by some experts because VSS is less inconvenient than a nocturnal sleep study and because VSS responses are more similar to normal sexually induced erections than are nocturnal erections.
Referral of the patient to a quali®ed mental health professional with experience in sexual dysfunction may be of substantial value in determining whether there is a signi®cant psychogenic element to a patient's ED. Urologists should not be hesitant to obtain the opinion of such a professional when the cause of a patient's ED is not clear.
Tests for reversible vasculogenic ED
The clinical application of diagnostic testing for vasculogenic ED is limited to young men with ED due to perineal or pelvic trauma, men who have a lifetime history of ED and men who have a genuine psychological need to know whether the cause of their ED is vasculogenic or psychogenic. Only a small percentage of men with ED are in these categories.
The purpose of an advanced penile vascular evaluation is to identify those young men who are candidates for penile vascular surgery. The ®rst step in the vascular evaluation is an intracavernous injection (ICI) test using vasoactive drugs to induce an erection. An inadequate response to ICI suggests vasculogenic dysfunction, although another common reason for an inadequate response is anxiety. An adequate response strongly suggests that the patient's ED is not vasculogenic although a patient may have mild cavernous arterial insuf®ciency even if he has a good response to ICI.
If the response to ICI is less than normal, the usual next step is duplex ultrasonography (DUS) of the corpora cavernosa. This study can identify both cavernous arterial and veno-occlusive pathology. The measurements obtained by DUS may vary with the technique and skill of the ultrasonographer, the time after intracavernous injection when it is performed and the patient's state of anxiety. Nevertheless, it has become a standard test in the diagnostic armamentarium of ED.
If DUS suggests that arterial pathology is present, penile arteriography can be performed to identify the location of arterial obstruction and to determine if the arterial tree distal to the obstruction is normal. Arteriography is needed for patients being considered for penile arterial revascularization but not for patients being considered for dorsal vein arterialization. Phalloarteriography does not produce physiological data and should not be used to make a diagnosis of cavernous arterial insuffuciency.
Corporo-venous occlusive dysfunction is diagnosed by cavernosometry. The¯ow to maintain a full erection following ICI is the key measurement on this study for identifying corporovenous occlusive dysfunction.
Dynamic infusion cavernosometry and cavernosography (DICC) may be used to identify both arteriogenic and veno-occlusive dysfunction. DICC is a complex test requiring expensive testing equipment not available to most practitioners. However, it can provide valuable and sophisticated diagnostic data. The cavernosography element of DICC provides only anatomic but not physiologic information. Because penile venous surgery is not effective in most men, there is rarely a reason to perform cavernosography.
Summary
Advanced diagnostic testing for reversible causes of ED which have speci®c therapy should be applied to only a small percentage of men with ED. These are men in whom there is a high degree of suspicion that hypogonadism, psychogenic or reversible vasculogenic is the cause of ED. In these men, identi®cation and treatment of these causes of ED can produce a permanent and dramatic improvement in sexual function and life satisfaction. 
Appendix
Open discussion following Dr Sharlip's presentation Dr Porst: How sure can you be that the standard patient does not have a vascular problem? When we make no vascular assessment in the so-called standard patient', we overlook those who must be referred for cardiovascular assessment prior to any therapy for erectile dysfunction.
Dr Sharlip: Maybe we should be referring all of our patients over 50 who have erectile dysfunction because perhaps they all have some form of coronary artery disease or atherosclerosis.
Dr Eid: With regard to diagnosis, it seems that very few physicians actually examine the penis. We don't teach penile exams in medical school. Evolving as a clinician over the last 10 y, I ®nd that the penile exam is a very useful tool in assessing bulk, elasticity and presence or absence of plaques.
Dr Melman: Every medical school has a women's health initiative where they have structured clinical examinations. At our medical school, we teach urologic expertise by doing physical examinations on the male, and that's the way we will get to the physicians of the future.
Dr Pryor: Do you really think that liver function tests should be obtained on everybody?
Dr Sharlip: It depends where you are; in some countries it might be impossible to get blood evaluations done. I get general chemistries and usually some screening for liver function tests and a creatinine. As practising urologists, I think we should be also be doing screening PSAs. Dr Eid: Often, by re-interviewing the patient, you get enough information that makes the NPT unnecessary. Also, sometimes you'll get an NPT in young men who clearly have a psychogenic component to their dysfunction.
Dr Montague: No, you don't always need it. I'm just making a plea. I've seen so many men with lifelong erectile dysfunction who are healthy men. They have no congenital abnormalities, they are not juvenile diabetics. Basically, everyone is looking for some physical cause for their erectile dysfunction.
In men who are adamant that they don't ever get a good erection, you ought to start out with a basic NPT.
